Skip to content

The impact of six-week dihydrogen-pyrroloquinoline quinone supplementation on mitochondrial biomarkers, brain metabolism, and cognition in elderly individuals with mild cognitive impairment: a randomized controlled trial.

Randomized controlled trial · J Nutr Health Aging · 2024. Source record refreshed; an explanation has not been reviewed.

Randomized controlled trialSource: PubMed · PMID 38908296

About this paper

This page identifies the publication and its source. A checked explanation of its findings is not yet available.

Reading this record

Checking bibliographic metadata does not verify a study’s conclusions or any advice previously linked to it.

CHECK THE ORIGINAL

Publication details

The impact of six-week dihydrogen-pyrroloquinoline quinone supplementation on mitochondrial biomarkers, brain metabolism, and cognition in elderly individuals with mild cognitive impairment: a randomized controlled trial.

Baltic S, Nedeljkovic D, Todorovic N et al.
J Nutr Health Aging · 2024

PubMed ID
38908296
Record checked

A checked publication record confirms source details. It does not verify a health claim or assess the quality of the study. Our approach.